A citation-based method for searching scientific literature

Stefanie K Wculek, Francisco J Cueto, Adriana M Mujal, Ignacio Melero, Matthew F Krummel, David Sancho. Nat Rev Immunol 2020
Times Cited: 401







List of co-cited articles
1078 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.
Hélène Salmon, Juliana Idoyaga, Adeeb Rahman, Marylène Leboeuf, Romain Remark, Stefan Jordan, Maria Casanova-Acebes, Makhzuna Khudoynazarova, Judith Agudo, Navpreet Tung,[...]. Immunity 2016
486
18

NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control.
Jan P Böttcher, Eduardo Bonavita, Probir Chakravarty, Hanna Blees, Mar Cabeza-Cabrerizo, Stefano Sammicheli, Neil C Rogers, Erik Sahai, Santiago Zelenay, Caetano Reis e Sousa. Cell 2018
553
17

Oncology meets immunology: the cancer-immunity cycle.
Daniel S Chen, Ira Mellman. Immunity 2013
16

Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity.
Mikhail Binnewies, Adriana M Mujal, Joshua L Pollack, Alexis J Combes, Emily A Hardison, Kevin C Barry, Jessica Tsui, Megan K Ruhland, Kelly Kersten, Marwan A Abushawish,[...]. Cell 2019
144
15

CD4+ T cell help in cancer immunology and immunotherapy.
Jannie Borst, Tomasz Ahrends, Nikolina Bąbała, Cornelis J M Melief, Wolfgang Kastenmüller. Nat Rev Immunol 2018
372
14

Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.
Stefani Spranger, Daisy Dai, Brendan Horton, Thomas F Gajewski. Cancer Cell 2017
545
14

A conserved dendritic-cell regulatory program limits antitumour immunity.
Barbara Maier, Andrew M Leader, Steven T Chen, Navpreet Tung, Christie Chang, Jessica LeBerichel, Aleksey Chudnovskiy, Shrisha Maskey, Laura Walker, John P Finnigan,[...]. Nature 2020
96
13

Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity.
Kai Hildner, Brian T Edelson, Whitney E Purtha, Mark Diamond, Hirokazu Matsushita, Masako Kohyama, Boris Calderon, Barbara U Schraml, Emil R Unanue, Michael S Diamond,[...]. Science 2008
12

Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny.
Martin Guilliams, Florent Ginhoux, Claudia Jakubzick, Shalin H Naik, Nobuyuki Onai, Barbara U Schraml, Elodie Segura, Roxane Tussiwand, Simon Yona. Nat Rev Immunol 2014
954
12

A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments.
Kevin C Barry, Joy Hsu, Miranda L Broz, Francisco J Cueto, Mikhail Binnewies, Alexis J Combes, Amanda E Nelson, Kimberly Loo, Raj Kumar, Michael D Rosenblum,[...]. Nat Med 2018
341
12

The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity.
Jan P Böttcher, Caetano Reis e Sousa. Trends Cancer 2018
139
12


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
11

Macrophages as regulators of tumour immunity and immunotherapy.
David G DeNardo, Brian Ruffell. Nat Rev Immunol 2019
432
11

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.
Christopher S Garris, Sean P Arlauckas, Rainer H Kohler, Marcel P Trefny, Seth Garren, Cécile Piot, Camilla Engblom, Christina Pfirschke, Marie Siwicki, Jeremy Gungabeesoon,[...]. Immunity 2018
285
11

Human dendritic cell subsets: an update.
Matthew Collin, Venetia Bigley. Immunology 2018
368
11

Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity.
Miranda L Broz, Mikhail Binnewies, Bijan Boldajipour, Amanda E Nelson, Joshua L Pollack, David J Erle, Andrea Barczak, Michael D Rosenblum, Adil Daud, Diane L Barber,[...]. Cancer Cell 2014
508
11

Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma.
Edward W Roberts, Miranda L Broz, Mikhail Binnewies, Mark B Headley, Amanda E Nelson, Denise M Wolf, Tsuneyasu Kaisho, Dusan Bogunovic, Nina Bhardwaj, Matthew F Krummel. Cancer Cell 2016
368
10

Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells.
Alfonso R Sánchez-Paulete, Francisco J Cueto, María Martínez-López, Sara Labiano, Aizea Morales-Kastresana, María E Rodríguez-Ruiz, Maria Jure-Kunkel, Arantza Azpilikueta, M Angela Aznar, José I Quetglas,[...]. Cancer Discov 2016
236
10

The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.
Miriam Merad, Priyanka Sathe, Julie Helft, Jennifer Miller, Arthur Mortha. Annu Rev Immunol 2013
10

The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Vinit Kumar, Sima Patel, Evgenii Tcyganov, Dmitry I Gabrilovich. Trends Immunol 2016
890
9

Understanding the tumor immune microenvironment (TIME) for effective therapy.
Mikhail Binnewies, Edward W Roberts, Kelly Kersten, Vincent Chan, Douglas F Fearon, Miriam Merad, Lisa M Coussens, Dmitry I Gabrilovich, Suzanne Ostrand-Rosenberg, Catherine C Hedrick,[...]. Nat Med 2018
9

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.
Naiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa S Ho,[...]. Science 2015
9

Natural killer cells and other innate lymphoid cells in cancer.
Laura Chiossone, Pierre-Yves Dumas, Margaux Vienne, Eric Vivier. Nat Rev Immunol 2018
339
8

Immunogenic cell death in cancer and infectious disease.
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, Laurence Zitvogel, Guido Kroemer. Nat Rev Immunol 2017
8

NK cells for cancer immunotherapy.
Noriko Shimasaki, Amit Jain, Dario Campana. Nat Rev Drug Discov 2020
194
8

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.
Sarah L Jongbloed, Andrew J Kassianos, Kylie J McDonald, Georgina J Clark, Xinsheng Ju, Catherine E Angel, Chun-Jen J Chen, P Rod Dunbar, Robert B Wadley, Varinder Jeet,[...]. J Exp Med 2010
730
8

Engineering dendritic cell vaccines to improve cancer immunotherapy.
Caleb R Perez, Michele De Palma. Nat Commun 2019
91
8

Delivery technologies for cancer immunotherapy.
Rachel S Riley, Carl H June, Robert Langer, Michael J Mitchell. Nat Rev Drug Discov 2019
496
8

cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity.
Stephen T Ferris, Vivek Durai, Renee Wu, Derek J Theisen, Jeffrey P Ward, Michael D Bern, Jesse T Davidson, Prachi Bagadia, Tiantian Liu, Carlos G Briseño,[...]. Nature 2020
65
12

A guide to cancer immunotherapy: from T cell basic science to clinical practice.
Alex D Waldman, Jill M Fritz, Michael J Lenardo. Nat Rev Immunol 2020
399
8

The immune contexture in human tumours: impact on clinical outcome.
Wolf Herman Fridman, Franck Pagès, Catherine Sautès-Fridman, Jérôme Galon. Nat Rev Cancer 2012
7

The immune contexture in cancer prognosis and treatment.
Wolf H Fridman, Laurence Zitvogel, Catherine Sautès-Fridman, Guido Kroemer. Nat Rev Clin Oncol 2017
762
7

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
7

Towards personalized, tumour-specific, therapeutic vaccines for cancer.
Zhuting Hu, Patrick A Ott, Catherine J Wu. Nat Rev Immunol 2018
330
7

Targeting macrophages: therapeutic approaches in cancer.
Luca Cassetta, Jeffrey W Pollard. Nat Rev Drug Discov 2018
460
7

MHC-II neoantigens shape tumour immunity and response to immunotherapy.
Elise Alspach, Danielle M Lussier, Alexander P Miceli, Ilya Kizhvatov, Michel DuPage, Adrienne M Luoma, Wei Meng, Cheryl F Lichti, Ekaterina Esaulova, Anthony N Vomund,[...]. Nature 2019
212
7

PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Paul C Tumeh, Christina L Harview, Jennifer H Yearley, I Peter Shintaku, Emma J M Taylor, Lidia Robert, Bartosz Chmielowski, Marko Spasic, Gina Henry, Voicu Ciobanu,[...]. Nature 2014
7

Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells.
Charles-Antoine Dutertre, Etienne Becht, Sergio Erdal Irac, Ahad Khalilnezhad, Vipin Narang, Shabnam Khalilnezhad, Pei Y Ng, Lucas L van den Hoogen, Jing Yao Leong, Bernett Lee,[...]. Immunity 2019
123
7

WDFY4 is required for cross-presentation in response to viral and tumor antigens.
Derek J Theisen, Jesse T Davidson, Carlos G Briseño, Marco Gargaro, Elvin J Lauron, Qiuling Wang, Pritesh Desai, Vivek Durai, Prachi Bagadia, Joshua R Brickner,[...]. Science 2018
92
7

Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.
Beatriz M Carreno, Vincent Magrini, Michelle Becker-Hapak, Saghar Kaabinejadian, Jasreet Hundal, Allegra A Petti, Amy Ly, Wen-Rong Lie, William H Hildebrand, Elaine R Mardis,[...]. Science 2015
688
7

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
Jérôme Galon, Anne Costes, Fatima Sanchez-Cabo, Amos Kirilovsky, Bernhard Mlecnik, Christine Lagorce-Pagès, Marie Tosolini, Matthieu Camus, Anne Berger, Philippe Wind,[...]. Science 2006
7

The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity.
Damya Laoui, Jiri Keirsse, Yannick Morias, Eva Van Overmeire, Xenia Geeraerts, Yvon Elkrim, Mate Kiss, Evangelia Bolli, Qods Lahmar, Dorine Sichien,[...]. Nat Commun 2016
120
7

Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors.
Alexandra-Chloé Villani, Rahul Satija, Gary Reynolds, Siranush Sarkizova, Karthik Shekhar, James Fletcher, Morgane Griesbeck, Andrew Butler, Shiwei Zheng, Suzan Lazo,[...]. Science 2017
960
7

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
7

Dendritic cell migration in health and disease.
Tim Worbs, Swantje I Hammerschmidt, Reinhold Förster. Nat Rev Immunol 2017
303
7


Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells.
Mercedes B Fuertes, Aalok K Kacha, Justin Kline, Seng-Ryong Woo, David M Kranz, Kenneth M Murphy, Thomas F Gajewski. J Exp Med 2011
653
7

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial.
Derin B Keskin, Annabelle J Anandappa, Jing Sun, Itay Tirosh, Nathan D Mathewson, Shuqiang Li, Giacomo Oliveira, Anita Giobbie-Hurder, Kristen Felt, Evisa Gjini,[...]. Nature 2019
450
7

Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells.
Brian Ruffell, Debbie Chang-Strachan, Vivien Chan, Alexander Rosenbusch, Christine M T Ho, Nancy Pryer, Dylan Daniel, E Shelley Hwang, Hope S Rugo, Lisa M Coussens. Cancer Cell 2014
440
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.